PAPER González-Domínguez R, García-Barrera T, Gómez-Ariza JL
SEARCH RESULTS
330026 RESULTS
PAPER Kanaan SF, McDowd JM, Colgrove Y, Burns JM, Gajewski B, Pohl PS
Feasibility and efficacy of intensive cognitive training in early-stage Alzheimer's disease.
Am J Alzheimers Dis Other Demen. 2014 Mar;29(2):150-8. PubMed: 24667905PAPER Lippa CF
Imaging and neuropsychological correlates of cognitive and behavioral symptoms in Alzheimer's disease.
Am J Alzheimers Dis Other Demen. 2014 Mar;29(2) PubMed: 24667903PAPER Song Y, Cui T, Xie N, Zhang X, Qian Z, Liu J
Protocatechuic acid improves cognitive deficits and attenuates amyloid deposits, inflammatory response in aged AβPP/PS1 double transgenic mice.
Int Immunopharmacol. 2014 May;20(1):276-81. Epub 2014 Mar 22 PubMed: 24667368PAPER Kosaraju J, Madhunapantula SV, Chinni S, Khatwal RB, Dubala A, Muthureddy Nataraj SK, Basavan D
Dipeptidyl peptidase-4 inhibition by Pterocarpus marsupium and Eugenia jambolana ameliorates streptozotocin induced Alzheimer's disease.
Behav Brain Res. 2014 Jul 1;267:55-65. Epub 2014 Mar 22 PubMed: 24667360PAPER Désesquelles A, Demuru E, Salvatore MA, Pappagallo M, Frova L, Meslé F, Egidi V
Mortality from Alzheimer's disease, Parkinson's disease, and dementias in France and Italy: a comparison using the multiple cause-of-death approach.
J Aging Health. 2014 Mar;26(2):283-315. PubMed: 24667337PAPER Jo C, Gundemir S, Pritchard S, Jin YN, Rahman I, Johnson GV
Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52.
Nat Commun. 2014 Mar 25;5:3496. PubMed: 24667209PAPER Paradela EM, Lourenço RA
Is the Cambridge Cognitive Examination- Revised a good tool for detection of dementia in illiterate Brazilian older adults?
Geriatr Gerontol Int. 2013 Oct 28; PubMed: 24666650PAPER Schäfer A, Burstein ES, Olsson R
Bexarotene prodrugs: targeting through cleavage by NQO1 (DT-diaphorase).
Bioorg Med Chem Lett. 2014 Apr 15;24(8):1944-7. Epub 2014 Mar 13 PubMed: 24666648PAPER Nan SJ, Han YQ, Fan J, Chen QH
Blepharospasm in familial AD secondary to an APP mutation (V715M).
Acta Neurol Belg. 2014 Mar 28; PubMed: 24677022PAPER Du GT, Hu M, Mei ZL, Wang C, Liu GJ, Hu M, Long Y, Miao MX, Chang Li J, Hong H
Telmisartan treatment ameliorates memory deficits in streptozotocin-induced diabetic mice via attenuating cerebral amyloidosis.
J Pharmacol Sci. 2014;124(4):418-26. Epub 2014 Mar 27 PubMed: 24671053PAPER Iikuni S, Ono M, Watanabe H, Matsumura K, Yoshimura M, Harada N, Kimura H, Nakayama M, Saji H
Enhancement of binding affinity for amyloid aggregates by multivalent interactions of 99mTc-hydroxamamide complexes.
Mol Pharm. 2014 Apr 7;11(4):1132-9. Epub 2014 Mar 27 PubMed: 24673484PAPER Gray ZA, Greenberg SM, Press DZ
rTMS for treatment of depression in a patient with cerebral amyloid angiopathy: a case report on safety and efficacy.
Brain Stimul. 2014 May-Jun;7(3):495-7. Epub 2014 Mar 4 PubMed: 24674781PAPER Prigatano GP, Montreuil M, Chapple K, Tonini A, Toron J, Paquet C, Dumurgier J, Hugon J, Truelle JL
Screening for cognitive and affective dysfunction in patients suspected of mild cognitive impairment.
Int J Geriatr Psychiatry. 2014 Sep;29(9):936-42. Epub 2014 Feb 12 PubMed: 24677206PAPER Rostamian S, Mahinrad S, Stijnen T, Sabayan B, de Craen AJ
Cognitive impairment and risk of stroke: a systematic review and meta-analysis of prospective cohort studies.
Stroke. 2014 May;45(5):1342-8. Epub 2014 Mar 27 PubMed: 24676778Current Filters
No filters selected